
Pooja Ghatalia
Associate Professor, Department of Hematology/Oncology · Temple University Hospital
Credentials: · · · · ·
History
Present
Present

- 2012–2015
Internal Medicine
- 2008–2012
Research
Review · Molecular Cancer Therapeutics · 2018 · 410 citations
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma
New England Journal of Medicine · 2024 · 152 citations
Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden
Journal for ImmunoTherapy of Cancer · 2018 · 129 citations

28 papers

27 papers

26 papers
- GS
15 papers

13 papers · 2 as a fellow

11 papers

9 papers

9 papers
Clinical trials
- 2026–2029
Principal investigator · Recruiting · Phase 2
Fox Chase Cancer Center
- 2023–2029
Enfortumab Vedotin Schedule De-escalation in Metastatic Urothelial Carcinoma
Principal investigator · Active not recruiting · Phase 2
Fox Chase Cancer Center
- 2020–2028
A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer
Principal investigator · Active not recruiting · Phase 2
Fox Chase Cancer Center


